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Antimycotic clotrimazole (CTZ) has demonstrated remarkable activity against Plasmodium falciparum 
in vitro and in vivo. Hemoglobin degradation by Plasmodium parasites makes amino acids available 
for protein synthesis, inducing oxidative stress in infected cells and producing free heme. These events 
represent biochemical targets for potential antimalarials. In this study, we have tested the ability of 
CTZ to modify the oxidative status in Plasmodium berghei-infected erythrocytes. After hemolysis, 
activities of superoxide dismutase (SOD), catalase (CAT), glutathione cycle and NADPH+H+–producing 
dehydrogenases were investigated using UV-visible spectrophotometry. Thiobarbituric acid reactive 
substances (TBARS) were evaluated as a marker of lipid damage. Results showed that CTZ significantly 
decreased the overall activity of 6-phosphagluconate dehydrogenase (6PGD) compared to infected and 
non-treated cells; consequently, the glutathione cycle was inhibited, leaving the parasite vulnerable to the 
oxidative stress originating from hemoglobin degradation. As a compensatory response, CTZ prevented 
some loss of SOD and CAT activities in infected cells. The infection triggered lipid peroxidation in 
erythrocytes, which was decreased by CTZ. These results suggest the presence of a redox unbalance in 
cells treated with CTZ, discussing a possible effect of this compound disturbing the oxidative status in 
a Plasmodium berghei-infection.
Uniterms: b-Hematin. Clotrimazole/modulatory ability/oxidative stress. Oxidative stress. Plasmodium 
berghei. Eritrócitos infectados
O antifúngico clotrimazol (CTZ) tem demonstrado notável atividade contra Plasmodium falciparum. 
A degradação da hemoglobina por Plasmodium para a obtenção dos aminoácidos necessários à síntese 
protéica induz estresse oxidativo em eritrócitos devido à liberação de hemos oxidantes. Estes eventos 
representam alvos bioquímicos para a produção de antimaláricos potenciais. Neste estudo, testamos a 
capacidade do CTZ para modificar o estado oxidativo em eritrócitos infectados com Plasmodium berghei. 
Depois da hemólise, as atividades da superóxido dismutase (SOD), catalase (CAT), desidrogenases 
produtoras de NADPH+H+ e do ciclo de glutationa (GSH) foram investigados. A produção das espécies 
reativas ao ácido tiobarbitúrico (TBARS) foi avaliada como marcador de dano lipídico. Os resultados 
mostraram que o CTZ diminuiu a atividade da 6-fosfogliconato desidrogenase (6PGD), em comparação 
com eritrócitos infectados e não tratados. Consequentemente, o ciclo da GSH foi inibido, tornando os 
parasitas vulneráveis ao estresse oxidativo resultante da degradação da hemoglobina. Como resposta 
compensatória, CTZ impediu a perda de atividade da SOD e CAT nas células infectadas. A infecção 
induz peroxidação lipídica nos eritrócitos, sendo esta diminuída pelo CTZ. Estes resultados sugerem 
a existência de desequilíbrio redox nas células tratadas com CTZ, interferindo, assim, com o estado 
oxidativo verificado durante a infecção malárica.
Unitermos: b-Hematina. Clotrimazol/capacidade modulatória/estresse oxidativo. Estresse oxidativo. 
Plasmodium berghei. Eritrócitos infectados.
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INTRODUCTION
Malaria is one of the more-frequently reported tropi-
cal disease worldwide. During 2008 alone, there were 247 
million cases of malaria and nearly one million deaths, 
mostly among children living in Africa, accounting for 
20% of all childhood deaths in that year (WHO 2008). Re-
sistance to antimalarial therapies has grown in an alarming 
manner during the past years, undermining malaria control 
efforts. Thus, to fight against this increasingly-resistant 
infectious disease, developing alternative therapies is a 
priority.
Hemoglobin proteolysis in intraerythrocytic ma-
laria parasites is a biochemical process that occurs in the 
acidic digestive vacuole of Plasmodium parasites by a 
group of proteases. This process provides free amino ac-
ids necessary for protein synthesis (Goldberg et al., 1990; 
Gamboa, Rosenthal, 1996). In this context, the oxidant 
heme group is separated from the globin chains in which 
Fe+2 is oxidized to form Fe+3, and the electrons produced 
react with molecular oxygen to form oxygen radicals 
(Francis et al., 1997; Atamna and Ginsburg, 1993; Mo-
han et al., 1992a). Parasites protect themselves from the 
deleterious effects of the free heme group by crystalliz-
ing part of the heme moieties into an insoluble non-toxic 
pigment called hemozoin or ß-hematin (Francis et al., 
1997; Bendrat et al., 1995). Meanwhile, the remainder 
of the heme moieties are detoxified by GSH-dependent 
degradation (Atamna and Ginsburg 2005). An alternative 
mechanism was proposed by Loria et al. (1999) which 
showed that hemoglobin oxidizes spontaneously due to 
the acidic environment of the digestive vacuole produc-
ing superoxide anion. This oxygen radical formation 
follows the production of H2O2 and the destruction of 
the porphyrin ring of the toxic heme.
Azole antimycotics have been reportedly acted 
as inhibitors of Plasmodium growth in culture and in 
vivo (Tiffert et al., 2000a; Raether and Seidenath, 1984; 
Rodrigues et al., 2011; Borhade et al., 2012). CTZ is ex-
ploited for its potential antimalarial effects by modifying 
the morphology of the parasites and through interference 
with its development and replication (Tiffert et al., 2000a). 
Moreover, this compound has been recently formulated in 
a nanoemulsion-based system with the aim of improving 
its solubility and dissolution, which can be further used 
in preclinical antimalarial evaluations (Borhade et al., 
2011; Borhade et al., 2012). Also, a series of heterocyclic 
azole-based compounds were described as inhibitors 
of P. falciparum lactate dehydrogenase at micromolar 
concentrations, and these compounds displayed modest 
activity against parasitized erythrocytes, including parasite 
strains with known resistance to existing antimalarials and 
against Plasmodium berghei in BALB/c mice (Cameron 
et al., 2004).
Previous reports have shown that different com-
pounds can modulate the oxidative status in infected 
erythrocytes. Quinoline compounds, such as chloroquine 
and dequalinium, can produce oxidative unbalance in 
parasitized erythrocytes in vitro (Ginsburg et al., 1998; 
Rodrigues, Gamboa 2009). Indeed, a recently synthe-
sized indanoyl-quinoline also exhibited antiamalarial 
properties by the inhibition of NADPH + H+-dependent 
dehydrogenases, glutathione peroxidase and glutathione-
S-transferase, inducing oxidative stress in infected red 
blood cells (Rodrigues et al., 2009). Also, the endoper-
oxide artemisinin is thought to react with heme moieties 
forming cytotoxic radicals producing a pro-oxidative 
environment, suggesting a mechanism of its antimalarial 
action (Becker et al., 2004).
In the search for new antimalarial compounds tar-
geting different antioxidant pathways, we have evaluated 
the ability of CTZ to modify the antioxidant defence in 
Plasmodium berghei-infected red blood cells. Thus, a 
deregulation in the normal malaria oxidative status could 
be responsible for the antimalarial mechanism of action 
of this compound, in addition to its ability to inhibit host 
hemoglobin degradation recently reported in Rodrigues 
et al. (2011).
MATERIAL AND METHODS
Drugs and animals
CTZ (Figure 1) was provided by CALOX Interna-
tional, based in Caracas, Venezuela. For in vitro assays, 
the drug was prepared as a 100 mM stock solution in di-
methyl sulfoxide (DMSO) and stored at 4 °C. All reagents 
were purchased at analytical grade from Sigma Company. 
Mice were housed under conditions approved by the 
Ethics Committee at the School of Pharmacy, Central 
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FIGURE 1 - Structure of the azole compound clotrimazole 
(CTZ).
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University of Venezuela (PG-CDCH- 06.30.5125-2007; 
FF-01032007).
Experimental host and strain maintenance
Male albino mice (BALB/c, 18-22 g) received a 
commercial pellet diet of Ratarina Protinal® (composition: 
proteins 26%, fats 2%, fibers 6%, nitrogen-free extracts 
40 %, vitamins A, B1, B12, D3, E, biotin, niacin, trace 
minerals Co, Cu, Fe, Mn, I and Zn) and water ad libitum. 
Plasmodium berghei-ANKA was used for the infections. 
Mice were infected intraperitoneally with 107 infected 
erythrocytes. Blood samples were removed when the ani-
mals reached 25% of parasitemia, and they were diluted in 
phosphate buffer solution (PBS 10 mM, pH 7.4, 0.1 mL). 
Parasitemia was monitored by microscopic examination 
of Giemsa stained smears.
Incubation of erythrocytes with CTZ
Non-infected erythrocytes (1x109) and Plasmo-
dium berghei–infected erythrocytes from mice (2-3% 
parasitemia and 4% hematocrit) were incubated in RPMI 
1640 medium (pH 7.3) supplemented with 20% foetal 
calf serum in the presence of CTZ (10 µM, large-scale 
cultures) (Janse, Waters 1995). After 24 hours of culture, 
non-treated infected erythrocytes mostly developed to 
the schizont stage, while the growth of treated (CTZ) 
and infected erythrocytes was arrested. Samples were 
centrifuged (5000 g x 10 min x 4 °C), washed with saline 
solution and hemolyzed.
Activities of superoxide dismutase (SOD) and 
catalase (CAT)
To determine the activity of SOD, samples were 
hemolyzed with 0.4 vol of chloroform/ethanol (1.5:1), 
and the activity was measured according to McCord 
and Fridovich (1969), which tracks the reduction of 
cytochrome c at 550 nm. For CAT activity, samples 
were hemolyzed with 4 vol of chilled water and diluted 
1:500 with phosphate buffer (pH 7.0) and activity was 
measured according to Aebi (1984), which tracks the 
reduction of H2O2 (30 mM) at 240 nm. The results were 
expressed as the percentage of decrease in activity 
compared to non-infected and non-treated erythrocytes 
(control cells).
Activities of dehydrogenase enzymes
To determine the activities of glucose-6-phosphate 
dehydrogenase (G6PD), 6-phosphogluconate dehy-
drogenase (6PGD) and isocitrate dehydrogenase (ID), 
samples were lysed (1:10) with a stabilized solution (5µL 
of b-mercaptoethanol, 1 mL of EDTA 10% and water to 
100 mL, pH 7.0). Measurements were determined ac-
cording to Bergmeyer et al., (1974), King (1974) and 
Bernt and Bergmeyer (1974) respectively. The results 
were expressed as a percentage of activity compared to 
non-infected and non-treated erythrocytes (control cells).
Glutathione cycle determinations
Total glutathione (GSH + GSSG) from erythrocytes 
were detected according to a modification of Tietze 
(1969). In short, samples were lysed with stabilized 
solution pH 7.0 (1:10) and 1 vol was added to 7 vol of a 
mixture that contained phosphate buffer (PBS, 10 mM, 
pH 7.5), NADPH + H+ (0.2 mM) and dinitro-benzene 
(DTNB, 0.6 mM). After adding glutathione reductase 
(10 µg/mL) to the samples, the increase in optical density 
at 412 nm was recorded, representing the formation of the 
reduced product, thionitrobenzene. A standard curve of 
GSH (0.02- 200 μM) was done in parallel. To determine 
glutathione peroxidase (GPx) activity, samples were 
lysed with stabilized solution (1:10) and measurements 
were taken according to Paglia and Valentine (1967) 
with a modification made by Flohé and Günzler (1984), 
which register NADPH + H+ oxidation at 340 nm. For 
glutathione S-transferase (GST) activity, samples were 
hemolyzed with stabilized solution (1:10) and measure-
ments were taken according to Habig et al., (1974), 
which tracks the conjugation of 1-Cl-2,4-dinitro benzene 
(CDNB, 1 mM) with reduced glutathione (5 mM) at 340 
nm. Results were expressed as a percentage of activity of 
the enzymes compared to non-infected and non-treated 
erythrocytes (control cells).
Determination of erythrocyte lipid peroxidation
To obtain membrane samples, erythrocytes were 
lysed through a treatment with PBS (5 mM pH=7.4) at 
4 °C (1:10). The hemolysate obtained was centrifuged 
(20000 g x 10 min at 4°C). Membrane pellets were washed 
three times with saline solution and stored at -80 ºC for 
24 hours. 
Erythrocyte lipid peroxidation was determined by 
measuring thiobarbituric acid (TBA) reactivity according 
to Buege and Aust (1978). In short, membrane samples 
were mixed with phosphoric acid 10% p/v in 0.1N HCl 
(1:6) and TBA (0.6% p/v in 0.1N HCl) (1:2). Samples were 
incubated in boiling water for 45 minutes and pretreated 
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with butylated hydroxytoluene (BHT, 20 µM) to avoid 
TBARS-level overestimation. Malondyaldehyde (MDA), 
the main product of lipid peroxidation reacts with TBA to 
form a coloured complex that has a maximum absorbance 
at 532 nm. 
Protein levels were determined according to Lowry 
et al. (1951). Data were presented as the average of four 
independent experiments (n=4) and tested for statistical 
significance using unpaired t-tests for specific group com-
parisons assuming 95% confidence limits using GraphPad 
Prism 4.02 software.
RESULTS
The antioxidant system represent a main pathway to 
detoxify free radicals produced during hemoglobin me-
tabolism in infected erythrocytes. Results of experiments 
on the main antioxidants in the presence of the azole com-
pound CTZ are expressed in Figures 2 and 3 and in Table I.
Our results show that the activity of the first line of 
antioxidant defense was significantly decreased due to 
the infection, since the overall SOD and CAT activities 
diminished. This event may be responsible for the presence 
of oxidative stress in the infected cells. However, CTZ 
treatment prevented some loss of activity of the SOD and 
CAT compared to untreated and infected cells (Figure 2).
The infection also effected the activities of NADPH 
+ H+-producing dehydrogenases (G6PD, 6PGLD and ID) 
showing significant increases in their activities compared 
to non-infected and untreated erythrocytes. This increase 
could be due to the high demand of this reducing co-factor 
during the infection. CTZ incubation resulted in a strong 
overall decrease in the activity of 6PGD in infected cells. 
This is one of the main enzymes of the hexose-monophos-
phate shunt, and it could represent a possible target for the 
antimalarial activity of new compounds (Figure 3).
The infection also led to increases in the overall 
activity of GST and in total glutathione levels, while no 
significant modifications were reported in GPx; however, 
CTZ decreased the activity of both enzymes (Table I), which 
could be due to the inhibition of one of the key enzymes 
of the hexose-monophosphate pathway by this compound. 
Plasmodium berghei infection promoted oxidative stress in 
infected cells, corroborated by higher levels of lipid peroxi-
dation. CTZ did not over-produce lipid damage; we detected 
significant protection against lipid peroxidation (Figure 4).
DISCUSSION
Mechanisms of the antimalarial activity of CTZ 
have been proposed in relation to Ca+2 ions. This drug 
inhibits the sarcoplasmic reticulum Ca+2 pump, causing 
the depletion of intracellular Ca+2 stores (Tiffert et al., 
2000b). This effect produces the activation of protein 
kinase R and phosphorylation of eukaryotic translation 
initiation factor 2α, leading to the inhibition of protein 
synthesis in parasites (Aktas et al., 1998). However, our 
group has demonstrated that this antimycotic azole can 
FIGURE 2 - The first line of the antioxidant defense enzymes in Plasmodium berghei-infected erythrocytes treated with clotrimazole 
(CTZ). Results are expressed as the mean ± SEM of the percentage of activity compared to non-infected and non-treated erythrocytes 
(NINT) (basal line). SOD: superoxide dismutase; CAT: catalase; NI + CTZ: non-infected red blood cells and treated with CTZ 
(white bars); I: infected erythrocytes (black bars); I+CTZ: infected red blood cells and treated with CTZ (gray bars); †p<0.001 
compared to NINT; *p<0.05 and ***p<0.001 compared to I.
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TABLE I - Effect of clotrimazole (CTZ) on the glutathione cycle in Plasmodium berghei-infected erythrocytes
Treatment GSH+GSSG (µmol/mg x 10-3) GPx (U/mg x 10-6) GST (U/mg x 10-3)
NI 10,18 ± 0,93 21,08 ± 0,52 40,37 ± 2,76
NI+CTZ 10,25 ± 1,16 22,14 ± 1,55 39,321 ± 2,05
I 20,17 ± 0,51*** 18,39 ± 1,6 59,39 ± 6,1 †
I+CTZ 21,72 ± 0,72 10,15 ± 1,67 ** 18,54 ± 1,38 **
Results are expressed as the mean ± SEM. NI: non-infected erythrocytes; I: infected erythrocytes; GSH: reduced glutathione; 
GSSG: oxidized glutathione; GPx: glutathione peroxidase; GST: glutathione S-transferase. †p<0.05; ***p<0.001 compared to NI; 
**p<0.01 compared to I.
FIGURE 3 - NADPH + H+-producing dehydrogenase enzymes in Plasmodium berghei-infected erythrocytes treated with 
clotrimazole (CTZ). Results are expressed as the mean ± SEM of the percentage of activity compared to non-infected and non-
treated erythrocytes (NINT) (basal line). G6PD: glucose-6-phosphate dehydrogenase; 6PGD: 6-phosphogluconate dehydrogenase; 
ID: isocitrate dehydrogenase; NI + CTZ: non-infected red blood cells and treated with CTZ (white bars); I: infected erythrocytes 
(black bars); I+CTZ: infected red blood cells and treated with CTZ (gray bars); †p<0.05 compared to NINT; **p<0.01 compared to I.
disturb hemoglobin metabolism in Plasmodium berghei-
infected erythrocytes through the inhibition of the heme 
crystallization, and this event could be responsible for its 
in vivo antimalarial actions (Rodrigues et al., 2011). Al-
though, the effects of CTZ on the oxidative/antioxidative 
routes, a subsequent pathways of hemoglobin metabolism 
and heme detoxification in infected red blood cells, are 
not well known.
Plasmodium parasites degrade host hemoglobin 
through aspartic and cysteine proteases to provide amino 
acids for protein synthesis (Goldberg 1992). In this pro-
cess, free toxic heme moieties crystallize spontaneously in 
the acid environment of the digestive vacuole to form an 
insoluble pigment called hemozoin or b-hematin (Orijh, 
Fitch, 1993). During this event, electrons are transferred 
from the ferrous ion of the heme to oxygen-producing free 
radicals, which, in consequence, could induce oxidative 
stress in infected cells (Becker et al., 2004). This may in-
volve the interaction between the parasite and the host cell, 
thereby producing modifications in several systems, by 
which the oxidative characterization must include different 
parameters. In this study, we show that these variables are 
susceptible to the effects of CTZ.
The expression of CAT appears to be increased in 
Plasmodium falciparum-infected erythrocytes (Clare-
bout et al., 1998); however, the activity of this enzyme is 
decreased in Plasmodium berghei infection, which could 
rise the levels of H2O2, leading the formation of hydroxyl 
radicals (Areekul, Boonme, 1986; Mohan et al., 1992b, 
Rodrigues, Gamboa, 2009). Previous studies have also 
shown that the overall activity of SOD is decreased due 
to the infection in Plasmodium falciparum, Plasmodium 
knowlesi and Plasmodium berghei-infected cells (Farombi 
et al., 2003; Srivastava et al., 1992; Rodrigues et al., 
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2009). The activity loss of the first line of antioxidant 
enzymes could be due to their income from the erythro-
cyte cytoplasm to the digestive vacuole in the parasite 
via endocitosis (Francis et al., 1997; Ginsburg, Atamna, 
1994). Indeed, in the acidic environment, the enzymes 
could be inactivated, which would increase the levels 
of free radicals in the infected-erythrocyte, promoting 
oxidative stress.
Our results are in concordance with reports cited 
previously, since we observed significant decreases in the 
overall activities of SOD and CAT in Plasmodium berghei-
infection, which could explain the oxidative stress and the 
perturbation in the erythrocyte antioxidant system observed 
in malarial disease. However, infected erythrocytes treated 
with CTZ prevented some loss of the activities of these 
enzymes compared to infected and untreated cells, confirm-
ing previous evidence in infected monkeys, mice treated 
with quinoline compounds, and in infected red blood cells, 
which could be due to a defense mechanism for the oxida-
tive stress triggered by the infection (Srivastava et al., 1992; 
Rodrigues, Gamboa, 2009; Rodrigues et al., 2009).
Key enzymes G6PD, 6PGD and ID are responsible 
for producing NADPH + H+ necessary for the adequate 
function of antioxidant cycles in red blood cells as thio-
redoxin and glutathione systems. We show that in Plas-
modium berghei-infected erythrocytes there is an increase 
in all of the dehydrogenase enzymes tested, compared to 
non-infected cells, which confirms the increased metabolic 
flow through the hexose-monophosphate shunt during the 
infection (Roth et al., 1982; Rodrigues, Gamboa 2009). 
In oxidative stress conditions, such as in Plasmodium-
infected cells, it is urgent to increase the NADPH + H+ 
levels used in the glutathione and thioredoxin cycles, 
therefore avoiding the deleterious effects of oxygen radi-
cals. However, treatment with CTZ showed decreases in 
the overall activity of the hexose-monophosphate enzyme 
6PGD, which could lead to a lower level of NADPH + H+ 
and promote a more sensitive state to oxidative stress in in-
fected cells, as well as decrease the ability of erythrocytes 
to detoxify oxygen radicals, as previously reported by our 
group with chloroquine and other quinoline-related struc-
tures (Rodrigues, Gamboa, 2009; Rodrigues et al., 2009). 
This effect should be added to the antimalarial properties 
of this compounds and shows that these enzymes could 
represent new targets for antimalarial chemotherapy, as 
it has been demonstrated for some antimalarials against 
purified G6PD (Cotton, Sutorious 1971).
The glutathione cycle is one of the major systems 
for avoiding the deleterious effects of free radicals. GPx 
and GST are known to use GSH as a substrate. Total 
glutathione levels and the overall activity of GST were 
increased due to the infection, which could be due to a 
detoxification function needed by the increased presence 
of radical metabolites, such as H2O2 and lipid peroxida-
tion products, while GPx was not significantly modified 
by the infection. CTZ decreased the overall activities of 
GPx and GST, and this inhibition could produce a more 
sensitive environment for parasites to develop oxidative 
stress linked to the hemoglobin degradation. Indeed, GPx 
inhibition follows an increase of H2O2 produced during 
FIGURE 4 - Effect of clotrimazole (CTZ) on lipid peroxidation in Plasmodium berghei-infected erythrocytes. Results are expressed 
as the mean ± SEM of MDA levels per mg of proteins. NINT: non-infected and non-treated erythrocytes; NI + CTZ: non-infected 
red blood cells and treated with CTZ; I: infected erythrocytes; I + CTZ: infected red blood cells and treated with CTZ. ***p<0.01 
compared I; †p<0.001 compared to NINT.
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the free heme detoxification (Loria et al., 1999). In this 
context, the endoperxide artemisinin generates free radi-
cals in part through its ability to inhibit GPx Plasmodium 
falciparum-infected erythrocytes (Itarrat et al., 2003).
The inhibition of GST by this antimycotic could lead 
to important modifications in the detoxification system, 
promoting an increase in toxic metabolites, such as hemin 
and peroxides. Inhibitors of this enzyme are parasitotoxic 
per se and might also prevent other antimalarials from be-
ing conjugated to glutathione, which could be useful in a 
combinatory therapy (Becker et al., 2004). It is important 
to remark that this enzyme also displays GSH-dependent 
peroxidase activity with H2O2 (Harwaldt et al., 2002). 
Compounds that inhibit this enzyme would lead to an in-
crease in this peroxide, which consequently would produce 
catalase activation as a compensatory response, as found 
in our results.
Further, CTZ produced alterations in the oxidative 
status by the possible decrease of NADPH + H+ due to the 
inhibited overall activity of 6PGD. Thus, the glutathione 
cycle would be compromised while SOD and CAT ac-
tivities could be over-activated to cope with the oxidative 
burst originated from the inhibition of the hexose-mono-
phosphate pathway and glutathione system. These effects 
could be responsible, at least in part, for the antimalarial 
activity recently reported for this compound (Rodrigues 
et al., 2011; Borhade et al., 2012).
On the other hand, CTZ has been reported as an 
inhibitor of the hemoperoxidase, increasing the accumula-
tion of H2O2 through the production of heme-clotrimazole 
adducts and causing a subsequent development of oxida-
tive stress in Plasmodium falciparum (Trivedi et al., 2005). 
This azole produces heme-induced hemolysis due to the 
inhibition of the glutathione-dependent heme degradation 
and not by lipid peroxidation, even though this oxidative 
event is present during the infection (Omodeo-Sale et al., 
2003; Rodrigues, Gamboa 2009). It appears that the en-
hancement of heme-induced hemolysis by CTZ is a result 
of a colloid osmotic mechanism (Huy et al., 2002). The 
hydrophobicity and the large molecular size of the heme-
clotrimazole complex may be key factors for the induction 
of this type of hemolysis (Huy et al., 2004). Indeed, our 
results show that this compound did not produce further 
lipid peroxidation. Instead, its levels were significantly 
decreased in infected cells treated with this compound.
CONLUSIONS
In this study, we show that CTZ modified the oxida-
tive status in infected erythrocytes through the interference 
in the hexose-monophosphate and the glutathione cycle, 
which could lead to increases in the overall activity of 
the first line of antioxidant enzymes. These encouraging 
results suggest that the in vitro and in vivo antimalarial 
activity showed by CTZ could also be due to a mechanism 
of action based on the despair of the oxidative status in 
infected red blood cells.
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